Invesco India Midcap Fund: Focusing on Quality Names in Midcap Domain

Jan 07, 2021

Despite the pandemic crisis, mid cap funds have generated significant gains in 2020, with the majority of schemes outpacing the index by a significant margin. In fact, recovery in the broader market after the pandemic-induced crash helped mid cap funds improve its performance compared to previous years (2018 and 2019).

We have observed a reduction in the degree of economic uncertainties after the lockdown restrictions were gradually lifted. Furthermore, RBI's liquidity infusion and the government's stimulus measures provided the much needed positive signals for the segment.

Though Mid cap funds may continue to do well in 2021 as the economy recovers further, be cautious of the risk involved. Advisably, invest in the mid cap segment only with a long term time frame preferably through mid cap schemes that focuses on fundamentally sound quality names while selecting stocks for the portfolio.

Invesco India Midcap Fund (IIMF) is a mid cap fund that invests in high growth-oriented quality stocks of mid-sized companies. The fund has registered superior outperformance in the recent corrective phase.

Graph 1: Growth of Rs 10,000 if invested in Invesco India Midcap Fund 5 years ago

Though IIMF’s performance in the past was ordinary, it has shown a turnaround performance in the last 2 years. By generating a compounded annualised return of around 14.8% over the past 5 years, IIMF has outpaced its benchmark Nifty Midcap 100 – TRI index by a compound annual growth rate (CAGR) of around 4 percentage points. The index has appreciated at 10.9% CAGR. An investment of Rs 10,000 in the fund 5 years back would have been valued at Rs 19,973. A simultaneous investment in the benchmark would now be worth Rs 16,768 over the same time period. The fund has done well during recovery and bullish market phases in the past. Moreover, IIMF has performed extremely well in the recent midcap crash which signifies its ability to perform under pressure and the potential to deliver superior risk-adjusted returns for its investors in the long run.

Graph 1
Data as on January 05, 2021
(Source: ACE MF)

Table: Invesco India Midcap Fund's performance vis-a-vis category peers

Scheme Name Corpus (Cr.) 1 Year (%) 2 Year (%) 3 Year (%) 5 Year (%) 7 Year (%) Std Dev Sharpe
Axis Midcap Fund 7,878 31.29 22.06 15.40 16.93 22.04 19.20 0.144
Quant Mid Cap Fund 20 48.39 21.33 13.06 13.09 14.18 23.29 0.107
PGIM India Midcap Opp Fund 471 56.22 28.89 11.97 14.06 17.05 25.23 0.093
Invesco India Midcap Fund 1,142 29.34 17.88 8.98 14.82 21.52 22.56 0.073
DSP Midcap Fund 9,467 27.09 19.67 8.04 15.06 20.95 22.09 0.062
Kotak Emerging Equity Fund 8,654 25.79 18.99 7.38 15.25 22.88 24.50 0.059
Nippon India Growth Fund 7,843 26.36 17.27 6.24 13.28 17.62 24.49 0.048
Franklin India Prima Fund 7,026 21.14 13.44 5.03 12.71 19.84 23.34 0.032
HDFC Mid-Cap Opportunities Fund 24,215 26.09 13.93 4.32 13.28 19.81 24.84 0.025
SBI Magnum Midcap Fund 4,113 34.01 17.73 3.89 10.46 18.53 25.93 0.020
Nifty Midcap 100 - TRI 25.71 11.53 1.01 10.88 16.51 27.77 0.004
Returns are point to point and in %, calculated using Direct Plan - Growth option. Those depicted over 1-Yr are compoundedannualised.
Data as on January 05, 2021
(Source: ACE MF)
*Please note, this table only represents the best performing funds based solely on past returns and is NOT a recommendation. Mutual Fund investments are subject to market risks. Read all scheme related documents carefully. Past performance is not an indicator for future returns. The percentage returns shown are only for indicative purposes.

With compounded annualised returns of around 29.3%, 17.9%, and 9%, respectively on a 1-year, 2-year and 3-year return basis, IIMF has managed to generate an alpha of 3.5 to 8 percentage points over the benchmark Nifty Midcap 100 - TRI.

The recent outperformance has helped it figure among the top quartile performers and has even scaled up its performance across time periods. On 5-year and 7-year return periods, the fund has managed to outpace the index by about 4 to 5 percentage points and has also outpaced the category average by a decent margin.

With a standard deviation of 22.56%, IIMF is prone to slightly lower volatility compared to the category average and the benchmark index. The fund has shown significant improvement in its risk-adjusted returns. Its Sharpe Ratio of 0.07 is much ahead of the benchmark and category average and indicates its ability to generate decent premium for the level of risk taken.

Investment strategy of Invesco India Midcap Fund

Classified under Mid Cap Funds, IIMF is mandated to invest at least 65% of its assets in equity & equity related instruments of mid cap companies. The fund house has positioned IIMF accordingly as a midcap fund that aims to invest in high growth oriented quality stocks of mid-sized companies. It usually holds 65% to 75% of its assets in the mid caps pool, with another 10% to 15% in small caps.

IIMF follows process based investment strategy and strictly adheres to its mandate and investment philosophy. While picking stocks, the fund managers look for stocks of companies with high growth potential. From the investment universe of over 300 midcap stocks, the fund has an active universe of around 135 stocks to choose from and holds a fairly diversified portfolio of around 30 to 50 stocks.

It follows the bottom-up and top-down approach to stock picking with no style bias. While the fund managers are in a constant hunt for high growth stocks available at reasonable valuations and look at timely entry and exit, moderate churning in IIMF's portfolio cannot be ruled out. Invesco India Mutual Fund follows proprietary investment framework, used since the inception of the organization and uses stock categorization framework to break / bucket stocks into growth and value style of investment. The fund stays fully invested and takes no cash calls.

As on December 31, 2020, IIMF held an exposure of around 65.9% in mid caps, along with 9.4% in small caps and 20.1% in large caps. The remaining 4.6% of its assets were held in cash and debt.

Graph 2: Top portfolio holdings in Invesco India Midcap Fund

Graph 2 Graph 2
Holding in (%) as on December 31, 2021
(Source: ACE MF)

As on December 31, 2021, IIMF held a reasonably sized portfolio of 44 stocks. The top 10 stocks together constitute around 31.9% of its assets. The top holdings in the portfolio contain midcap names like L&T Technology Services, Coromandel International, Balkrishna Industries, Mphasis, Whirlpool of India, etc. The fund also has some large cap names like ICICI Bank and Gland Pharma in its top portfolio holdings.

Names like Apollo Hospitals Enterprise, Coromandel International, Ajanta Pharma, Mphasis, Balkrishna Industries, Muthoot Finance, and Tube Investments of India, among others contributed immensely to the fund's performance in the last one year.

IIMF's portfolio is currently diversified across a host of cyclical and defensive sectors. Financial Services form its top holding with an allocation of around 17.6%, followed by Engineering, Auto ancillaries, Pharma, Consumer Durables, and Infotech with an allocation in the range of 7-10% in each. The top 10 sectors together account for around 78% of its assets.


IIMF belongs to a fund house driven by strong investment systems and processes. The focus on fundamentally sound quality names in the mid cap domain has helped IIMF reward its investors even in depressed market conditions. IIMF has a superior track record of outperformance over its benchmark index and the category average over longer time periods. However being benchmark agnostic, its performance may at times be in contrast to the midcap index and also its peers that hold significant exposure to momentum driven mid-caps. This makes IIMF suitable for aggressive investors having a long term investment horizon.


Warm Regards,
Divya Grover
Research Analyst


PS: PersonalFN has completed 20 years of unbiased research service and we want to celebrate it with our loyal readers and subscribers like yourself. Get PersonalFN's model mutual fund portfolio service 'FundSelect Plus' in this exclusive anniversary offer. As a FundSelect Plus subscriber, you will get access to 7 ready-to-invest premium mutual fund solutions with high performance potential. Subscribe now!

Note: This write up is for information purpose and does not constitute any kind of investment advice or a recommendation to Buy / Hold / Sell a fund. Returns mentioned herein are in no way a guarantee or promise of future returns. As an investor, you need to pick the right fund to meet your financial goals. If you are not sure about your risk appetite, do consult your investment consultant/advisor. Mutual Fund Investments are subject to market risks, read all scheme related documents carefully.


Join Now: PersonalFN is now on Telegram. Join FREE Today to get ‘Daily Wealth Letter’ and Exclusive Updates on Mutual Funds



About the Company including business activity

Quantum Information Services Private Limited (QIS) was incorporated on December 19, 1989.

QIS was promoted by Mr Ajit Dayal with an objective of providing value-based information/views on news related to equity markets, the economy in general, sector analysis, budget review and various personal products and investments options available to the Public. It was the first company to start equity research on an institutional level.

'PersonalFN' is a service brand of QIS and was started in the year 1999. In 1999, the Company registered the Domain name for providing information on mutual funds and personal financial planning, financial markets in general, etc. and services related to financial planning and research in various financial instruments including mutual funds, insurance and fixed income products to customers. It offers asset allocation and researched investment recommendations through its financial planning services.

Quantum Information Services Private Limited (QIS) is registered as Investment Adviser under SEBI (Investment Adviser) Regulations, 2013 and having Registration No.: INA000000680. In terms of the second proviso to Regulation 3 (1) of SEBI (Research Analysts) Regulations, 2014 the Company is not required to obtain Certificate of registration from SEBI.

Disciplinary history

There are no outstanding litigations against the Company, its subsidiaries and its Directors.

Terms and condition on which its offer research report

For the terms and condition for research report click here.

Details of associates

  1. Money Simplified Services Private Limited;

  2. PersonalFN Insurance Services India Private Limited;

  3. Equitymaster Agora Research Private Limited;

  4. Common Sense Living Private Limited;

  5. Quantum Advisors Private Limited;

  6. Quantum Asset Management Company Private Limited;

  7. India Private Limited;

  8. HelpYourNGO Foundation;

  9. Natural Streets for Performing Arts Foundation;

  10. Primary Real Estate Advisors Private Limited;

  11. HYNGO India Private Limited;

  12. Suresh Lulla;

  13. I V Subramaniam.

Disclosure with regard to ownership and material conflicts of interest
  1. ‘subject company’ is a scheme on which a buy/sell/hold view or target price is given/changed in this Research Report;

  2. Neither QIS, it's Associates, Research Analyst or his/her relative have any financial interest in the subject Company; except for one of the Research Analysts holding units of SBI Focused Equity Fund;

  3. Neither QIS, it's Associates, Research Analyst or his/her relative have actual/beneficial ownership of one per cent or more securities of the subject Company, at the end of the month immediately preceding the date of publication of the research report;

  4. Neither QIS, it's Associates, Research Analyst or his/her relative has any other material conflict of interest at the time of publication of the research report except that QIS (PersonalFN) is, as per SEBI (Mutual Funds) Regulations 1996, an associate / group Company of Quantum Asset Management Company Private Limited and Trustees and Sponsor of Quantum Mutual Fund (QMF) and to that extent there may be conflict of interest while recommending any schemes of QMF. However, any such recommendation or reference made is based on the standard evaluation and selection process, which applies uniformly for all Mutual Fund Schemes. The payment of commission (upfront / annualized & trail), if any, for any Schemes by QMF to QIS (PersonalFN) is also at arm's length and as per prevailing market practices.

Disclosure with regard to receipt of Compensation
  1. Neither QIS nor it's Associates have received any compensation from the subject Company in the past twelve months;

  2. Neither QIS nor it's Associates have managed or co-managed public offering of securities for the subject Company;

  3. Neither QIS nor it's Associates have received any compensation for investment banking or merchant banking or brokerage services from the subject Company;

  4. Neither QIS nor it's Associates have received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months.

  5. Neither QIS nor it's Associates have received any compensation or other benefits from the subject Company or third party in connection with the research report

General disclosure
  1. The Research Analyst has not served as an officer, director or employee of the subject Company.

  2. QIS or the Research Analyst has not been engaged in market making activity for the subject Company.

Click here to read PersonalFN's Mutual Fund Rating Methodology

Subject Company means Mutual Fund Schemes

Quantum Information Services Private Limited CIN: U65990MH1989PTC054667 Regd. & Corp. Office: 103, Regent Chambers, 1st Floor, Nariman Point, Mumbai - 400 021 Website: Tel.: 022 61361200 Fax.: 022 61361222 SEBI-registered Investment Adviser. Registration No. INA000000680, SEBI (Investment Advisers) Regulation, 2013

Add Comments